Leslie Trigg - Nov 16, 2023 Form 4 Insider Report for Outset Medical, Inc. (OM)

Role: Chair and CEO, Director
Signature: By: John L Brottem For: Leslie Trigg
Stock symbol: OM
Transactions as of: Nov 16, 2023
Transactions value $: -$15,113
Form type: 4
Date filed: 11/17/2023, 04:19 PM
Previous filing: Aug 17, 2023
Next filing: Jan 8, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OM	Common Stock	Sale	-$15.1K	-3.18K	-0.78%	$4.76	403K	Nov 16, 2023	Direct	F1, F2
holding	OM	Common Stock						8.77K	Nov 16, 2023	Trigg Family Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,892 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021 and January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2	Includes 1 share of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of March 1, 2023 to August 31, 2023. This transaction is exempt from Rule 16b-3(c).

Content

Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,892 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021 and January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Includes 1 share of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of March 1, 2023 to August 31, 2023. This transaction is exempt from Rule 16b-3(c).